Latest market price
54.94
+0.05+0.09%
TA
Loading chart...
Snapshot
| Index | - | P/E | 22.06 | EPS (ttm) | 2.49 | Insider Own | 5.21% | Shs Outstand | 54.94M | Perf Week | 0.29% |
| Market Cap | 3.02B | Forward P/E | 12.26 | EPS next Y | 4.48 | Insider Trans | 0.00% | Shs Float | 48.59M | Perf Month | 0.48% |
| Enterprise Value | 4.45B | PEG | 2.04 | EPS next Q | - | Inst Own | - | Short Float | 4.41% | Perf Quarter | 23.57% |
| Income | 149.00M | P/S | 1.09 | EPS this Y | 15.36% | Inst Trans | - | Short Ratio | 1.63 | Perf Half Y | 79.13% |
| Sales | 2.78B | P/B | 1.58 | EPS next Y | 7.46% | ROA | 3.21% | Short Interest | 2.14M | Perf YTD | 8.90% |
| Book/sh | 34.82 | P/C | 167.70 | EPS next 5Y | 12.34% | ROE | 7.96% | 52W High | 56.41 -2.61% | Perf Year | 2.14% |
| Cash/sh | 0.33 | P/FCF | 10.83 | EPS past 3/5Y | -3.08% 5.35% | ROIC | 4.19% | 52W Low | 24.29 126.18% | Perf 3Y | 3.25% |
| Dividend Est. | - | EV/EBITDA | 12.73 | Sales past 3/5Y | 25.00% 23.40% | Gross Margin | 13.03% | Volatility | 0.20% 0.17% | Perf 5Y | 57.51% |
| Dividend TTM | - | EV/Sales | 1.60 | EPS Y/Y TTM | 219.23% | Oper. Margin | 8.49% | ATR (14) | 0.14 | Perf 10Y | 393.62% |
| Dividend Ex-Date | - | Quick Ratio | 1.52 | Sales Y/Y TTM | 53.12% | Profit Margin | 5.33% | RSI (14) | 71.43 | Recom | 2.80 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.52 | EPS Q/Q | 19.80% | SMA20 | 0.30% | Beta | 0.89 | Target Price | 44.75 |
| Payout | 0.00% | Debt/Eq | 1.00 | Sales Q/Q | 1.15% | SMA50 | 0.43% | Rel Volume | 0.64 | Prev Close | 54.89 |
| Employees | 9,500 | LT Debt/Eq | 0.96 | Earnings | Feb 24 | SMA200 | 37.03% | Avg Volume | 1.52M | Price | 54.94 |
| IPO Date | Apr 27, 1995 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -5.53% -3.42% | Net Debt/EBITDA | 4.11 | Volume | 977,635 | Change | 0.09% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-23-26 | Downgrade | William Blair | Outperform → Market Perform | |
| Sep-16-26 | Downgrade | Barrington Research | Outperform → Market Perform | |
| Jul-30-26 | Reiterated | US Capital Advisors | $55 | |
| Jul-30-26 | Downgrade | CJS Securities | Market Outperform → Market Perform | |
| Jun-24-26 | Initiated | Barrington | Outperform | $45 |
| May-01-26 | Reiterated | Stephens | $31 → $37 | |
| Apr-30-26 | Reiterated | Deutsche Bank | $40 → $42 | |
| Apr-09-26 | Initiated | Stephens | Equal Weight | $31 |
| Jan-12-26 | Initiated | Deutsche Bank | Hold | $60 |
| Aug-12-24 | Upgrade | Sidoti & Co. | Neutral → Buy |
Latest News· Times ET
Oct-21-26
Oct-19-26
07:58AM
CBIZ (NYSE:CBZ) Releases Earnings Resultsdefenseworld.net
06:30AM
02:32AM
Oct-12-26
Oct-08-26
10:41AM
Oct-05-26
Oct-01-26
Sep-28-26
Sep-27-26
Sep-22-26
Sep-21-26
Company
CBIZ, Inc. is a professional services firm that delivers a broad spectrum of financial, insurance, and advisory solutions across the United States and Canada. The company's operations are organized into three principal divisions: Financial Services, Benefits and Insurance Services, and National Practices. Within its Financial Services segment, CBIZ offers expertise in areas such as accountancy and taxation, financial guidance, asset appraisal, risk assessment, and consulting for government healthcare. The Benefits and Insurance Services division focuses on workforce welfare program consultation, compensation and human resources administration, general property and casualty coverage, and pension planning alongside investment solutions. Lastly, the National Practices segment specializes in comprehensive IT infrastructure and hardware management, coupled with specialized healthcare advisory services. CBIZ primarily caters to small and medium-sized enterprises, private individuals, public sector organizations, and various non-profit ventures. The firm was established in 1987 and maintains its principal offices in Cleveland, Ohio.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,776 | 2,758 | 1,813 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,414 | 2,403 | 1,631 | — | — | — | — | — | — | |
| Gross Profit | 361 | 355 | 182 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 126 | 121 | 109 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Operating Income | 235 | 234 | 74 | — | — | — | — | — | — | |
| Interest Expense | 98 | 107 | 34 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 70 | 34 | 18 | — | — | — | — | — | — | |
| Net Income Before Taxes | 208 | 161 | 58 | — | — | — | — | — | — | |
| Income Taxes | 59 | 45 | 17 | — | — | — | — | — | — | |
| Consolidated Net Income | 149 | 115 | 41 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 149 | 115 | 41 | — | — | — | — | — | — | |
| Net Income | 149 | 115 | 41 | — | — | — | — | — | — | |
| EPS (Recurring) | 2.50 | 1.83 | 0.78 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 2.50 | 1.83 | 0.78 | — | — | — | — | — | — | |
| EPS (Diluted) | 2.49 | 1.83 | 0.78 | — | — | — | — | — | — | |
| EBITDA | 350 | 366 | 140 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 22.06 | 27.57 | 104.91 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.19 | 1.15 | 2.35 | — | — | — | — | — | — | |
| Gross Margin | 13.00 | 12.87 | 10.04 | — | — | — | — | — | — | |
| Operating Margin | 8.47 | 8.48 | 4.08 | — | — | — | — | — | — | |
| Net Margin | 5.37 | 4.17 | 2.26 | — | — | — | — | — | — | |
| Shares Outstanding | 60 | 63 | 52 | — | — | — | — | — | — | |
| Market Capitalization | 3,296 | 3,178 | 4,255 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SHERMAN A HAAG | Director | Aug 04 '26 | Option Exercise | 24.62 | 50,000 | 1,231,000 | 70,125 | Aug 05 |
| Lakhia Brad S. | Senior Vice President & CFO | Mar 13 '26 | Buy | 25.97 | 12,775 | 331,719 | 148,480 | Mar 17 |
| YOUNG RODNEY A | Director | Mar 13 '26 | Buy | 26.05 | 1,000 | 26,055 | 9,310 | Mar 17 |
| WILEY BENAREE PRATT | Director | Mar 10 '26 | Sale | 26.39 | 17,956 | 473,913 | 18,000 | Mar 11 |
| Kouzelos Michael P | President, Employee Services | Feb 08 '26 | Option Exercise | 0.00 | 3,053 | 0 | 365,646 | Feb 10 |
| GRISKO JEROME P | CEO & President | Feb 08 '26 | Option Exercise | 0.00 | 9,454 | 0 | 69,186 | Feb 10 |
| WILEY BENAREE PRATT | Director | Dec 02 '25 | Sale | 49.54 | 8,288 | 410,612 | 35,956 | Dec 04 |
| Lakhia Brad S. | Senior Vice President & CFO | Nov 26 '25 | Buy | 48.51 | 2,060 | 99,931 | 40,584 | Dec 01 |
| YOUNG RODNEY A | Director | Aug 08 '25 | Buy | 62.43 | 2,000 | 124,860 | 8,310 | Aug 12 |
| Lakhia Brad S. | Senior Vice President & CFO | Aug 04 '25 | Buy | 62.78 | 1,593 | 100,014 | 38,524 | Aug 05 |
| DeGroote Michael H | Director | Oct 14 '21 | Sale | 34.72 | 8,362 | 290,329 | 124,592 | Mar 31 |
| GROVE WARE H | C.F.O. | Mar 14 '25 | Sale | 70.16 | 4,029 | 282,679 | 301,518 | Mar 18 |
| WILEY BENAREE PRATT | Director | Mar 06 '25 | Sale | 71.75 | 6,526 | 468,214 | 41,759 | Mar 10 |
| SPURIO CHRIS | President, Financial Services | Feb 11 '25 | Option Exercise | 0.00 | 4,143 | 0 | 221,845 | Feb 13 |
| Kouzelos Michael P | President, Employee Services | Feb 11 '25 | Option Exercise | 0.00 | 3,748 | 0 | 349,135 | Feb 13 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.